DNAPrint Pharmaceuticals To Present At NYSSA Biotech/Specialty Pharma Conference

Published: Dec 05, 2006

SARASOTA, FL -- (MARKET WIRE) -- December 05, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that Chairman and Chief Medical Officer Hector J. Gomez, M.D., Ph.D., will present an overview of the Company's wholly owned subsidiary DNAPrint Pharmaceuticals, Inc. to investors at the 10th Annual New York Society of Securities Analysts (NYSSA) Biotech/Specialty Pharma Conference on Tues., Dec. 12, 2006 at 1:40 p.m. Eastern time, at the Association's headquarters, 1177 Ave. of the Americas, in New York City.

Back to news